Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14615376rdf:typepubmed:Citationlld:pubmed
pubmed-article:14615376lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:14615376lifeskim:mentionsumls-concept:C0253457lld:lifeskim
pubmed-article:14615376lifeskim:mentionsumls-concept:C1504389lld:lifeskim
pubmed-article:14615376lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:14615376lifeskim:mentionsumls-concept:C0011155lld:lifeskim
pubmed-article:14615376lifeskim:mentionsumls-concept:C0205470lld:lifeskim
pubmed-article:14615376lifeskim:mentionsumls-concept:C1513380lld:lifeskim
pubmed-article:14615376lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:14615376pubmed:issue6lld:pubmed
pubmed-article:14615376pubmed:dateCreated2004-3-4lld:pubmed
pubmed-article:14615376pubmed:abstractTextWe found 10 individuals from 7 unrelated families among 170 severe combined immunodeficiency (SCID) patients who exhibited 9 different Janus kinase 3 (JAK3) mutations. These included 3 missense and 2 nonsense mutations, 1 insertion, and 3 deletions. With the exception of 1 individual with persistence of transplacentally transferred maternal lymphocytes, all infants presented with a T-B+NK- phenotype. The patient mutations all resulted in abnormal B-cell Janus kinase 3 (JAK3)-dependent interleukin-2 (IL-2)-induced signal transducer and activator of transcription-5 (STAT5) phosphorylation. Additional analyses of mutations permitting protein expression revealed the N-terminal JH7 (del58A) and JH6 (D169E) domain mutations each inhibited receptor binding and catalytic activity, whereas the G589S JH2 mutation abrogated kinase activity but did not affect c association. Nine of the 10 patients are currently alive from between 4 years and 18 years following stem cell transplantation, with all exhibiting normal T-cell function. Reconstitution of antibody function was noted in only 3 patients. Natural killer (NK) function was severely depressed at presentation in the 4 patients studied, whereas after transplantation the only individuals with normal NK lytic activity were patients 1 and 5. Hence, bone marrow transplantation is an effective means for reconstitution of T-cell immunity in this defect but is less successful for restoration of B-cell and NK cell functions.lld:pubmed
pubmed-article:14615376pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14615376pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14615376pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14615376pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14615376pubmed:languageenglld:pubmed
pubmed-article:14615376pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14615376pubmed:citationSubsetAIMlld:pubmed
pubmed-article:14615376pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14615376pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14615376pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14615376pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14615376pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14615376pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14615376pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14615376pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14615376pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14615376pubmed:statusMEDLINElld:pubmed
pubmed-article:14615376pubmed:monthMarlld:pubmed
pubmed-article:14615376pubmed:issn0006-4971lld:pubmed
pubmed-article:14615376pubmed:authorpubmed-author:O'SheaJohn...lld:pubmed
pubmed-article:14615376pubmed:authorpubmed-author:BuckleyRebecc...lld:pubmed
pubmed-article:14615376pubmed:authorpubmed-author:DannW JWJlld:pubmed
pubmed-article:14615376pubmed:authorpubmed-author:ZhouYong-JieY...lld:pubmed
pubmed-article:14615376pubmed:authorpubmed-author:LengiAndreaAlld:pubmed
pubmed-article:14615376pubmed:authorpubmed-author:RobertsJoseph...lld:pubmed
pubmed-article:14615376pubmed:authorpubmed-author:BrownStephani...lld:pubmed
pubmed-article:14615376pubmed:issnTypePrintlld:pubmed
pubmed-article:14615376pubmed:day15lld:pubmed
pubmed-article:14615376pubmed:volume103lld:pubmed
pubmed-article:14615376pubmed:ownerNLMlld:pubmed
pubmed-article:14615376pubmed:authorsCompleteYlld:pubmed
pubmed-article:14615376pubmed:pagination2009-18lld:pubmed
pubmed-article:14615376pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:14615376pubmed:meshHeadingpubmed-meshheading:14615376...lld:pubmed
pubmed-article:14615376pubmed:meshHeadingpubmed-meshheading:14615376...lld:pubmed
pubmed-article:14615376pubmed:meshHeadingpubmed-meshheading:14615376...lld:pubmed
pubmed-article:14615376pubmed:meshHeadingpubmed-meshheading:14615376...lld:pubmed
pubmed-article:14615376pubmed:meshHeadingpubmed-meshheading:14615376...lld:pubmed
pubmed-article:14615376pubmed:meshHeadingpubmed-meshheading:14615376...lld:pubmed
pubmed-article:14615376pubmed:meshHeadingpubmed-meshheading:14615376...lld:pubmed
pubmed-article:14615376pubmed:meshHeadingpubmed-meshheading:14615376...lld:pubmed
pubmed-article:14615376pubmed:meshHeadingpubmed-meshheading:14615376...lld:pubmed
pubmed-article:14615376pubmed:meshHeadingpubmed-meshheading:14615376...lld:pubmed
pubmed-article:14615376pubmed:meshHeadingpubmed-meshheading:14615376...lld:pubmed
pubmed-article:14615376pubmed:meshHeadingpubmed-meshheading:14615376...lld:pubmed
pubmed-article:14615376pubmed:meshHeadingpubmed-meshheading:14615376...lld:pubmed
pubmed-article:14615376pubmed:meshHeadingpubmed-meshheading:14615376...lld:pubmed
pubmed-article:14615376pubmed:meshHeadingpubmed-meshheading:14615376...lld:pubmed
pubmed-article:14615376pubmed:meshHeadingpubmed-meshheading:14615376...lld:pubmed
pubmed-article:14615376pubmed:meshHeadingpubmed-meshheading:14615376...lld:pubmed
pubmed-article:14615376pubmed:meshHeadingpubmed-meshheading:14615376...lld:pubmed
pubmed-article:14615376pubmed:meshHeadingpubmed-meshheading:14615376...lld:pubmed
pubmed-article:14615376pubmed:meshHeadingpubmed-meshheading:14615376...lld:pubmed
pubmed-article:14615376pubmed:meshHeadingpubmed-meshheading:14615376...lld:pubmed
pubmed-article:14615376pubmed:meshHeadingpubmed-meshheading:14615376...lld:pubmed
pubmed-article:14615376pubmed:meshHeadingpubmed-meshheading:14615376...lld:pubmed
pubmed-article:14615376pubmed:year2004lld:pubmed
pubmed-article:14615376pubmed:articleTitleJanus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation.lld:pubmed
pubmed-article:14615376pubmed:affiliationDepartment of Pediatrics, Duke University Medical Center, Durham, NC 27710, USA. rober060@mc.duke.edulld:pubmed
pubmed-article:14615376pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14615376pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
entrez-gene:3718entrezgene:pubmedpubmed-article:14615376lld:entrezgene
entrez-gene:3640entrezgene:pubmedpubmed-article:14615376lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:14615376lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14615376lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14615376lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14615376lld:pubmed